References in periodicals archive ?
APN401 is an individual adoptive cell therapy in which human peripheral blood mononuclear cells are silenced ex- vivo for Cbl-b (an E3 ubiquitin ligase) using small interfering ribonucleic acid (siRNA), thereby activating them to fight cancer more efficiently.
For HIV, we have used a small interfering ribonucleic acid (siRNA) targeted to CCR5.
HOUSTON -- The newly established Small Interfering Ribonucleic Acid (siRNA) Facility at M.

Full browser ?